Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs ...

Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer’s disease. Some 138 treatments are being ...

The National Institute for Health and Care Excellence is taking more evidence and is expected to announce its decision in the ...

A third of the drugs that are currently being trialled are 'repurposed' medications that are already being used to tackle other diseases, including diabetes and multiple sclerosis ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow ...

A "sub-study" of a large clinical trial found the drug, obicetrapib, significantly reduced levels of a type of tau protein ...

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety ...

Merck & Co. said its oral PCSK9 inhibitor candidate enlicitide hit its key goals in a pair of late-stage studies in adults with high cholesterol. Merck, which is evaluating the safety and efficacy ...

But the cause of high cholesterol is multifactorial, and for some people, cholesterol-lowering medications like statins aren’t effective. In a new study led by the Cleveland Clinic, researchers ...

Merck, which is evaluating the safety and efficacy of enlicitide for the treatment of adults with hyperlipidemia on lipid-lowering therapies, including at least a statin, said the Phase 3 studies met ...